| Form 1-K Issuer Information |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-K | OMB APPROVAL |
| OMB Number: 3235-0720 Estimated average burden hours per response: 600.0 |
1-K: Filer Information
| Issuer CIK | 0001698370 |
| Issuer CCC | XXXXXXXX |
| Is filer a shell company? | 
Yes
No
|
| Is the electronic copy of an official filing submitted in paper format? |  |
| File Number | |
| Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination? |
Yes
No
|
| Successor File Number |
| Is this a LIVE or TEST Filing? |
LIVE
TEST
|
| Would you like a Return Copy? | |
| Period | 03-31-2018 |
| Name | |
| Phone | |
| E-Mail Address |
| Notify via Filing Website only? | |
1-K: Tab 1 Notification
| This Form 1-K is to provide an |
Annual Report
Special Financial Report for the fiscal year
|
| Fiscal Year End | 03-31-2018 |
| Exact name of issuer as specified in the issuer's charter | TRUE LEAF MEDICINE INTERNATIONAL LTD. |
| CIK | 0001698370 |
| Jurisdiction of Incorporation / Organization |
BRITISH COLUMBIA, CANADA
|
| I.R.S. Employer Identification Number | 00-0000000 |
| Address 1 | 100 KALAMALKA LAKE ROAD |
| Address 2 | UNIT 32 |
| City | VERNON |
| State/Country |
BRITISH COLUMBIA, CANADA
|
| Mailing Zip/ Postal Code | V1T 9G1 |
| Phone | 778-389-9933 |
| Title of each class of securities issued pursuant to Regulation A | Common Stock |
1-K: Summary Information Regarding Prior Offering and Proceeds
Summary Information
The following information must be provided for any Regulation A
offering that has terminated or completed prior to the filing of
this Form 1-K, unless such information has been previously reported
in a manner permissible under Rule 257. If such information has been
previously reported, check this box and leave the rest of Part I
blank.
| Commission File Number of the offering statement | 024-10679 |
| Date of qualification of the offering statement | 11-21-2018 |
| Date of commencement of the offering | 11-23-2018 |
| Amount of securities qualified to be sold in the offering | 14285715 |
| Amount of securities sold in the offering | 14285715 |
| Price per security |
$
0.7000 |
| The portion of aggregate sales attributable to securities sold on behalf of the issuer |
$
10000000.00 |
| The portion of the aggregate sales attributable to securities sold on behalf of selling securityholders |
$
0.00 |
Fees in connection with this offering and names of service providers.
| Underwriters - Name of Service Provider | Boustead Securities LLC | Underwriters - Fees |
$
800000.00 |
| Sales Commissions - Name of Service Provider | Fintech Clearing LLC/ Flashfunder | Sales Commissions - Fee |
$
55764.00 |
| Finders' Fees - Name of Service Provider | Finders' Fees - Fees |
$
| |
| Accounting or Audit - Name of Service Provider | Davidson & Company LLP | Accounting or Audit - Fees |
$
13056.00 |
| Legal - Name of Service Provider | Venture Law Corporation Horwitz Armstrong LLP | Legal - Fees |
$
80033.00 |
| Promoters - Name of Service Provider | Promoters - Fees |
$
| |
| Blue Sky Compliance - Name of Service Provider | Blue Sky Compliance - Fees |
$
|
| CRD Number of any broker or dealer listed | 141391 |
| Net proceeds to the issuer |
$
7934140.00 |
| Clarification of responses (if necessary) | Amounts are in CDN dollars. Underwriters also received warrants to purchase 6% of the securities issued in this offering at $1.05 per share. Underwriters' warrants and underlying shares (857,143 shares) are also being qualified in this offering. |